Hepatitis A and e infection in international travellers

Current Infectious Disease Reports

Volumn 13, Issue 3, 2011, Pages 248-255

  Torresi, Joseph ^a,b   Johnson, Douglas ^a  

^a AUSTIN HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Hepatitis A; Hepatitis E; Liver failure; Travellers; Vaccines

Indexed keywords

DRINKING WATER; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A TYPHOID VACCINE; HEPATITIS A VACCINE; HEPATITIS E VACCINE; HEPATYRIX; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PLACEBO; UNCLASSIFIED DRUG; VACCINE; VIVAXIM;

AFRICA; ANTIBODY DETECTION; ARGENTINA; ARTICLE; ASIA; BANGLADESH; CENTRAL AMERICA; DRUG ABUSE; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATALITY; FOOD CONTAMINATION; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; INCIDENCE; INDIA; INFECTION RISK; MIDDLE EAST; NORTH AFRICA; PREGNANCY; RISK REDUCTION; SEROPREVALENCE; SEXUAL TRANSMISSION; SOUTH AMERICA; SWITZERLAND; TRAVEL; TYPHOID FEVER; VIRUS TRANSMISSION; WATER CONTAMINATION;

EID: 79956194193     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-011-0179-7     Document Type: Article

References (52)

1. T Loscher JS Keystone R Steffen 1999 Vaccination of travelers against hepatitis A and B J Travel Med 6 107 114 10381963 10.1111/j.1708-8305.1999. tb00841.x 1:STN:280:DyaK1Mzhs1Cntw%3D%3D (Pubitemid 29252120)
2. SM Lemon RW Jansen EA Brown 1992 Genetic, antigenic and biological differences between strains of hepatitis A virus Vaccine 10 Suppl 1 S40 S44 1335657 10.1016/0264-410X(92)90540-Z
3. M Mutsch VM Spicher C Gut, et al. 2006 Hepatitis A virus infections in travelers, 1988-2004 Clin Infect Dis 42 490 497 16421793 10.1086/499816 (Pubitemid 43202521)
4. •• Askling HH, Rombo L, Andersson Y, et al. Hepatitis A risk in travelers. J Travel Med. 2009;16:233-8. This article provides an excellent review of hepatitis A in travellers.
5. R Steffen MA Kane CN Shapiro, et al. 1994 Epidemiology and prevention of hepatitis A in travelers JAMA 272 885 889 8078167 10.1001/jama.272.11.885 1:STN:280:DyaK2czlvV2ruw%3D%3D (Pubitemid 24282100)
6. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis-United States, 2007. Centers for Disease Control and Prevention (CDC). MMWR Surveill Summ. 2009 May 22;58(3):1-27. Available at http://www.cdc.gov/ mmwr/preview/mmwrhtml/ss5803a1.htm.
7. Guerrant RL, Walker DH, Weller PF. Tropical infectious diseases: principles, pathogens, & practice. 2nd ed. Philadelphia: Elsevier Churchill Livingstone; 2006.
8. The Australian Immunisation Handbook 9th Edition 2008. Available at http://immunise.health.gov.au/internet/immunise/publishing.nsf/Content/ Handbook-hepatitisa.
9. BA Connor 2005 Hepatitis A vaccine in the last-minute traveler Am J Med 118 Suppl 10A 58S 62S 16271543 10.1016/j.amjmed.2005.07.018 (Pubitemid 41552434)
10. Wiersma S. CDC Yellow Book Chapter 2 Hepatitis A. CDC; 2010 [cited 2010 31-8-2010]. Available at http://wwwnc.cdc.gov/travel/yellowbook/2010/chapter-2/ hepatitis-a.aspx.
11. R Clemens A Safary A Hepburn, et al. 1995 Clinical experience with an inactivated hepatitis A vaccine J Infect Dis 171 Suppl 1 S44 S49 7876648 10.1093/infdis/171.Supplement-1.S44
12. A Hepatitis 1995 Vaccine Med Lett Drugs Ther 37 51 52
13. K Van Herck P Van Damme M Lievens, et al. 2004 Hepatitis A vaccine: indirect evidence of immune memory 12 years after the primary course J Med Virol 72 194 196 14695659 10.1002/jmv.10574 (Pubitemid 38020545)
14. JC Laurence 2005 Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus Am J Med 118 Suppl 10A 75S 83S 16271546 10.1016/j.amjmed.2005.07.024 (Pubitemid 41552437)
15. Immunisation against infectious disease. Available at http://www.dh.gov.uk/prod-consum-dh/groups/dh-digitalassets/@dh/@en/documents/ digitalasset/dh-121552.pdf.
16. AS Craig W Schaffner 2004 Prevention of hepatitis A with the hepatitis A vaccine N Engl J Med 350 476 481 14749456 10.1056/NEJMcp031540 1:CAS:528:DC%2BD2cXos1Squw%3D%3D (Pubitemid 38133768)
17. Update: Prevention of Hepatitis A After Exposure to Hepatitis A Virus and in International Travelers. Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP). Available at http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm5641a3.htm.
18. P D'Argenio B Adamo R Cirrincione, et al. 2003 The role of vaccine in controlling hepatitis A epidemics Vaccine 21 2246 2249 12744851 10.1016/S0264-410X(03)00140-3 (Pubitemid 36561315)
19. G Taliani GB Gaeta 2003 Hepatitis A: post-exposure prophylaxis Vaccine 21 2234 2237 12744848 10.1016/S0264-410X(03)00138-5 (Pubitemid 36561312)
20. A Werzberger B Mensch B Kuter, et al. 1992 A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children N Engl J Med 327 453 457 1320740 10.1056/NEJM199208133270702 1:STN:280:DyaK38zis12jsA%3D%3D
21. B Kaic B Borcic M Ljubicic, et al. 2001 Hepatitis A control in a refugee camp by active immunization Vaccine 19 3615 3619 11395194 10.1016/S0264-410X(01) 00103-7 1:STN:280:DC%2BD3MzivVSqtg%3D%3D (Pubitemid 32522758)
22. •• Victor JC, Monto AS, Surdina TY, et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med. 2007;357:1685-94. This is a very important publication demonstrating the effectivenss of hepatitis A vaccine compared to immunoglobulin in disease outbreaks. (Pubitemid 350005150)
23. BJ McMahon M Beller J Williams, et al. 1996 A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine Arch Pediatr Adolesc Med 150 733 739 8673200 1:STN:280:DyaK283ptVClsA%3D%3D (Pubitemid 26230875)
24. •• Dalton HR, Bendall R, Ijaz S, et al. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis. 2008;8:698-709. This article provides an excellent review of hepatitis E.
25. •• Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol. 2009;24:1484-93. This excellent review describes the global distribution of the major genotypes of hepatitis E virus.
26. IK Mushahwar 2008 Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention J Med Virol 80 646 658 18297720 10.1002/jmv.21116 (Pubitemid 351358563)
27. N Piper-Jenks HW Horowitz E Schwartz 2000 Risk of hepatitis E infection to travelers J Travel Med 7 194 199 11003732 10.2310/7060.2000.00059 1:STN:280:DC%2BD3cvltFamtw%3D%3D
28. BC Cowie A Breschkin H Kelly 2005 Hepatitis E virus: overseas epidemics and Victorian travellers Med J Aust 183 491 16274355 (Pubitemid 41671786)
29. A Labrique K Nelson 2010 Hepatitis E virus infections among US military personnel deployed to Afghanistan J Infect Dis 202 1297 1299 20863229 10.1086/656599
30. AB Labrique K Zaman Z Hossain, et al. 2009 Population seroprevalence of hepatitis E virus antibodies in rural Bangladesh Am J Trop Med Hyg 81 875 881 19861625 10.4269/ajtmh.2009.09-0352
31. AB Labrique K Zaman Z Hossain, et al. 2010 Epidemiology and risk factors of incident hepatitis E virus infections in rural Bangladesh Am J Epidemiol 172 952 961 20801864 10.1093/aje/kwq225
32. VA Arankalle SA Tsarev MS Chadha, et al. 1995 Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992 J Infect Dis 171 447 450 7844387 10.1093/infdis/171.2.447 1:STN:280:DyaK2M7ks1Oqug%3D%3D
33. I Potasman L Koren M Peterman, et al. 2000 Lack of hepatitis E infection among backpackers to tropical countries J Travel Med 7 208 210 11003735 10.2310/7060.2000.00062 1:STN:280:DC%2BD3cvltFamug%3D%3D
34. RD Smalligan WR Lange JD Frame, et al. 1995 The risk of viral hepatitis A, B, C, and E among North American missionaries Am J Trop Med Hyg 53 233 236 7573702 1:STN:280:DyaK28%2FjtlSjsQ%3D%3D
35. ET Clayson BL Innis KS Myint, et al. 1995 Short report: relative risk of hepatitis A and E among foreigners in Nepal Am J Trop Med Hyg 52 506 507 7611554 1:STN:280:DyaK2MzjsF2ksw%3D%3D
36. IK Mushahwar GJ Dawson KM Bile, et al. 1993 Serological studies of an enterically transmitted non-A, non-B hepatitis in Somalia J Med Virol 40 218 221 8355020 10.1002/jmv.1890400309 1:STN:280:DyaK3szlvFyqsg%3D%3D (Pubitemid 23204098)
37. K Bile A Isse O Mohamud, et al. 1994 Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia Am J Trop Med Hyg 51 466 474 7943574 1:STN:280: DyaK2M%2FjtVWlsA%3D%3D (Pubitemid 24324763)
38. P Colson P Borentain B Queyriaux, et al. 2010 Pig liver sausage as a source of hepatitis E virus transmission to humans J Infect Dis 202 825 834 20695796 10.1086/655898
39. A Kumar R Aggarwal SR Naik, et al. 2004 Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region Indian J Gastroenterol 23 59 62 15176538 (Pubitemid 38622981)
40. S Singh A Mohanty YK Joshi, et al. 2003 Mother-to-child transmission of hepatitis E virus infection Indian J Pediatr 70 37 39 12619951 10.1007/BF02722743 (Pubitemid 36249584)
41. S Sookoian 2006 Liver disease during pregnancy: acute viral hepatitis Ann Hepatol 5 231 236 17060891 (Pubitemid 44444600)
42. F Legrand-Abravanel N Kamar K Sandres-Saune, et al. 2010 Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France J Infect Dis 202 835 844 20695798 10.1086/655899 1:CAS:528:DC%2BC3cXht1CltL3N
43. HR Dalton RP Bendall FE Keane, et al. 2009 Persistent carriage of hepatitis E virus in patients with HIV infection N Engl J Med 361 1025 1027 19726781 10.1056/NEJMc0903778 1:CAS:528:DC%2BD1MXhtVyjsrbO
44. R Gerolami V Moal P Colson 2008 Chronic hepatitis E with cirrhosis in a kidney-transplant recipient N Engl J Med 358 859 860 18287615 10.1056/NEJMc0708687 1:CAS:528:DC%2BD1cXitFOiur8%3D (Pubitemid 351281667)
45. N Kamar J Selves JM Mansuy, et al. 2008 Hepatitis E virus and chronic hepatitis in organ-transplant recipients N Engl J Med 358 811 817 18287603 10.1056/NEJMoa0706992 1:CAS:528:DC%2BD1cXitFOit7k%3D (Pubitemid 351281642)
46. EB Haagsma AP van den Berg RJ Porte, et al. 2008 Chronic hepatitis E virus infection in liver transplant recipients Liver Transplant 14 547 553 10.1002/lt.21480 (Pubitemid 351524412)
47. SM Hosseini-Moghaddam A Zarei SM Alavian, et al. 2010 Hepatitis E virus infection: a general review with a focus on hemodialysis and kidney transplant patients Am J Nephrol 31 398 407 20357431 10.1159/000294505
48. A Kumar M Beniwal P Kar, et al. 2004 Hepatitis E in pregnancy Int J Gynaecol Obstet 85 240 244 15145258 10.1016/j.ijgo.2003.11.018 1:STN:280:DC%2BD2c3kslWiuw%3D%3D (Pubitemid 38622553)
49. J Drobeniuc J Meng G Reuter, et al. 2010 Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances Clin Infect Dis 51 e24 e27 20578874 10.1086/654801
50. MS Chadha AM Walimbe VA Arankalle 1999 Retrospective serological analysis of hepatitis E patients: a long-term follow-up study J Viral Hepat 6 457 461 10607264 10.1046/j.1365-2893.1999.00190.x 1:STN:280:DC%2BD3c%2FnsFansA%3D%3D
51. • Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007;356:895-903. This article is a key publication on a hepatitis E vaccine candidate. (Pubitemid 46339908)
52. •• Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010;376:895-902. This article describes a well-conducted and very large trial reporting on a highly efficacious hepatitis E vaccine candidate.